BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29862302)

  • 1. Association between
    Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
    J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between
    Zhao H; Zhang H; Wang Y; Zhao T; Yan M; Dong X; Wang Q; Li J; Ma L; Li P
    J Diabetes Res; 2020; 2020():5424701. PubMed ID: 32685558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of UNC13B Gene Polymorphisms and Diabetic Kidney Disease in a Chinese Han Population.
    Wang Y; Tan J; Liu D; Yang Y; Wu H
    Med Sci Monit; 2019 Nov; 25():8527-8533. PubMed ID: 31713534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MYH9 Polymorphisms with Hypertension in Patients with Chronic Kidney Disease in China.
    Liu L; Wang C; Mi Y; Liu D; Li L; Fan J; Nan L; Jia N; Du Y
    Kidney Blood Press Res; 2016; 41(6):956-965. PubMed ID: 27924804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between LXR-
    Liu P; Ma L; Zhao H; Shen Z; Zhou X; Yan M; Zhao T; Zhang H; Qiu X; Li P
    J Diabetes Res; 2020; 2020():8721536. PubMed ID: 33426085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort.
    Tavira B; Coto E; Gómez J; Tranche S; Miguélez K; Ortega F; Díez B; Sánchez E; Marín R; Arenas J; Alvarez V
    Gene; 2013 May; 520(1):73-6. PubMed ID: 23470845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYH9 gene polymorphisms may be associated with cerebrovascular blood flow in patients with type 2 diabetes.
    Ling C; Cai CY; Chang BC; Shi WT; Wei FJ; Yu P; Chen LM; Li WD
    Genet Mol Res; 2015 Feb; 14(1):1008-16. PubMed ID: 25730040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
    Colares VS; Titan SM; Pereira Ada C; Malafronte P; Cardena MM; Santos S; Santos PC; Fridman C; Barros RT; Woronik V
    PLoS One; 2014; 9(3):e87716. PubMed ID: 24658608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
    O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
    Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
    Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
    Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the GFR-related gene and the SNP-SNP interactions on the risk of diabetic kidney disease in Chinese Han population.
    Liu Y; Chen Y; Yang Q; Shen D; Du Z; Zhang G
    Acta Diabetol; 2023 Jan; 60(1):115-125. PubMed ID: 36378321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between RBMS1 gene rs7593730 and BCAR1 gene rs7202877 and Type 2 diabetes mellitus in the Chinese Han population.
    Kazakova EV; Chen M; Jamaspishvili E; Lin Z; Yu J; Sun L; Qiao H
    Acta Biochim Pol; 2018; 65(3):377-382. PubMed ID: 30188962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphism rs2032487 in the non-muscle myosin heavy chain IIA gene (MHY9) and chronic kidney disease secondary to type 2 diabetes mellitus in a population of the Canary Islands.
    Boronat M; Tugores A; Saavedra P; Garay P; Bosch E; Lorenzo D; García-Cantón C
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Dec; 66(10):639-646. PubMed ID: 30954444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.